I know that this post is dead for 3 years now, but I had the same problem and I know that many people are looking for an answer. What they are telling me is that tagmentase is an extremely labile enzyme and it is enough for it to be a little bit outdated or to have several freeze-thaw cycles to lose most of its activity. Hence very large library sizes - tagmentation is just not good enough, and increasing its duration will not help because the enzyme is inactive. Better switch to other methods of DNA shearing.
Unconfigured Ad
Collapse
X
-
Eh? Who are the "they" to whom you refer? Nextera doesn't seem particularly labile to me.Originally posted by rudzik79 View PostI know that this post is dead for 3 years now, but I had the same problem and I know that many people are looking for an answer. What they are telling me is that tagmentase is an extremely labile enzyme and it is enough for it to be a little bit outdated or to have several freeze-thaw cycles to lose most of its activity. Hence very large library sizes - tagmentation is just not good enough, and increasing its duration will not help because the enzyme is inactive. Better switch to other methods of DNA shearing.
One point of possible confusion: after tagmentation, but before PCR, everything tends to look very big because the Tn5 has inserted but apparently it still tethering both DNA ends to each other. See here for more details:
Haplotype-resolved genome sequencing enables the accurate interpretation of medically relevant genetic variation, deep inferences regarding population history and non-invasive prediction of fetal genomes. We describe an approach for genome-wide haplotyping based on contiguity-preserving transpositio …
This paper describes a "contiguity preserving transposition based sequencing" method that takes advantage of this behavior of Tn5.
--
Phillip
Comment
-
Yes, I think it is possible that rudzik79 did not read the entire thread prior to posting. Which one could understand, I suppose. But in this case led to an erroneous assumption as to the "aliveness" of the thread...Originally posted by GenoMax View PostReally
Last posting in this thread was on 20th April of this year by @fanli
--
Phillip
Comment
Latest Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
Yesterday, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 02:55 AM
|
0 responses
9 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 02:55 AM
|
||
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
12 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
12 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
24 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
Comment